Transplant Diagnostic Market – Snapshot

The global transplant diagnostic market is expanding due to the increasing number of patients emphasizing on early patient profiling during organ transplantation and rising adoption of transplant diagnostic techniques. The global transplant diagnostic market was valued at US$ 730.9 Mn in 2017 and is projected to surpass US$ 1,289.3 Mn by 2026, expanding at a compound annual growth rate (CAGR) of more than 6.5% from 2018 to 2026. The global market is expanding at a relatively higher growth rate owing to increasing bone marrow transplantation practices, high incidences of pediatric transplantation surgery, occurrence of kidney disorder among geriatric population, and increasing clinical evidence to establish clinical efficacy of molecular assay technique.

Transplant diagnostic is an administrative as well as clinical tool that helps improve operational efficiency of transplantation technique. Transplant diagnostic aids the patients suffering from cancer in order to improve overall operational efficiency as well as patient care. High prevalence and incidence rates of kidney dysfunction, cardiac diseases, increase in number of cases of lungs disorder and orthopedic injuries in the global population has led to the increase in patient flow to private clinics and hospitals. These factors, collectively, are projected to drive the demand for transplant diagnostic in the near future. Furthermore, the compatibility of markers increases the probability of graft survival and decreases severe immunologic transplant complications, which in turn is estimated to fuel the transplant diagnostic market in the near future.

transplant-diagnostics-market.jpg

The global transplant diagnostic market has been broadly segmented based on screening, technique, product & services, application, end-user, and region. In terms of application, the global market has been categorized into stem cell transplantation and solid organ transplantation. The solid organ transplantation segment has been further sub-segmented into kidney, liver, heart, lungs, pancreas, and small bowel. The kidney transplant sub-segment accounted for a key share of the solid organ transplantation segment, in terms of revenue, of the global market in 2017. The liver sub-segment is estimated to expand at a prominent growth rate during the forecast period, and the sub-segment is estimated to report significant gain in market share by the end of 2026. Liver transplant diagnostic is increasingly gaining popularity among cancer patients and physicians, which is also a major factor that is estimated to drive the liver sub-segment between 2018 and 2026.

In terms of technique, the global transplant diagnostic has been classified into molecular assay and non-molecular assay. The non-molecular assay segment dominated the global market and is likely to maintain its dominance by the end of 2026 with marginal increase in its year-on-year growth rate. Rapid advances in the fields of transplant medicine and cancer treatment and the ever-growing implementation of immunomodulatory regimens led to significant increase in the prevalence and prolonged survival of people in immunocompromised states. These are key factors which have led the non-molecular assay segment to hold a prominent share of the global market. Based on screening, the transplant diagnostic market has been bifurcated into pre-transplant diagnostic and post-transplant diagnostic. In terms of product & services, the transplant diagnostic market has been split into reagents & consumables, instruments, and software. Based on end-user, the global market has been segregated into hospital & transplant centers, research laboratories, and others.

In terms of region, the global transplant diagnostic market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market and is projected to lose market share by the end of 2026. The market in North America is primarily driven by the rapid increase in geriatric population, high adoption rate of transplantation technique for cancer, and rise in incidence of kidney disorders among geriatric population in the U.S. Moreover, increasing awareness programs about transplantation by pharmaceutical companies is a major practice witnessed in the U.S., which is projected to fuel the transplant diagnostic market in the U.S. during the forecast period. The market in Asia Pacific is expected to expand at a rapid pace during the forecast period. China dominated the transplant diagnostic market in Asia Pacific, whereas the market in India is estimated to expand at a significant CAGR during the forecast period.

Companies such as Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., and Becton, Dickinson and Company accounted for a major share of the global transplant diagnostic market in 2017 In July 2017, Thermo Fisher Scientific acquired Linkage Biosciences. Linkage Biosciences is presently a part of Thermo Fisher's transplant diagnostics business. Through this acquisition, Thermo Fisher currently provides services to more than 1,000 transplant centres in more than 60 countries. Other global players operating in the market include Ortho Clinical Diagnostics (a part of Carlyle Group), Immucor, Inc., Illumina, Inc., Siemens Healthineers (Siemens AG), and Agilent Technologies. Companies are adopting the strategy of acquisition and collaboration with parallel companies in order to improve and strengthen its geographic presence in the global market.

Transplant Diagnostic Market - Overview

This report on the transplant diagnostic market analyzes the current and future scenario of the global market. Rising incidence of chronic diseases such as chronic kidney disease (CKD), end-stage renal disease, coronary artery disease, and acute & chronic hepatitis among all age groups, particularly the geriatric population, is increasing the usage of transplant diagnostic techniques owing to the rise in organ transplantation. Increase in success rates of transplantation and favorable reimbursement policies and frequent funding are the major drivers of the global transplant diagnostic market.

The transplant diagnostic market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on screening, technique, application, product & services, end-user, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Additionally, the section comprises major player’s product portfolio-based on technology & application to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global transplant diagnostic market.

Based on application, the market has been segmented into stem cell transplantation and solid organ transplantation. The solid organ transplantation segment has been further sub-segmented into kidney, liver, heart, lungs, pancreas, and small bowel. The application segments have been analyzed based on available cost-effectiveness and preference use of technologies by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Based on technique, the transplant diagnostic market has been classified into molecular assay and non-molecular assay. In terms of screening, the transplant diagnostic market has been segregated into pre-transplant diagnostic and post-transplant diagnostic. The market segments have been extensively analyzed based on prevalence of the chronic diseases, available transplant treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2018 to 2026, considering 2017 as the base year

Based on end-user, the transplant diagnostic market has been split into hospital & transplant centers, research laboratories, and others. In terms of product & services, the transplant diagnostic market has been classified into reagents & consumables, instruments, and software & services based on the product & services. The market segments have been extensively analyzed based on prevalence of the diseases, awareness levels among people about organ donations, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of region, the global transplant diagnostic market has been segmented into five major regions and the key countries in the respective regions are: North America (U.S., Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global transplant diagnostic market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include EMS Electro Medical Systems S.A., BTL corporate, Dornier MedTech GmbH, and Zimmer MedizinSysteme GmbH., Siemens AG, Boston Scientific Corporation, NCELER MEDICAL LTD, and Guangzhou Longest Science & Technology Co.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global transplant diagnostic market has been segmented as given below:

Screening

  • Pre-Transplant Diagnostic
  • Post-Transplant Diagnostic

Technique

  • Molecular Assay
  • Non-Molecular Assay

Application

  • Solid Organ Transplantation
    • Kidney
    • Liver
    • Heart
    • Lungs
    • Pancreas
    • Small Bowel
    • Stem Cell Transplantation

Product & Services

  • Reagents & Consumables
  • Instruments
  • Software & Services

End-user

  • Hospitals
  • Clinics
  • Rehab centers
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Transplant Diagnostic Market

4. Market Overview
     4.1. Introduction
            4.1.1. Technique Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunity
            4.3.4. Trends
     4.4. Global Transplant Diagnostic Market Analysis and Forecast, 2016–2026
            4.4.1. Market Revenue Projections (US$ Mn)
     4.5. Market Outlook
     4.6.Regulatory Scenarios
     4.7. Number of Transplantations, by Region/Country
     4.8. Key Success Factors of Top 3 Companies

5. Global Transplant Diagnostic Market Analysis and Forecast, by Technique
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Global Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
            5.3.1. Molecular Assay
            5.3.2. Non-Molecular Assay
     5.4. Market Attractiveness, by Technique

6. Global Transplant Diagnostic Market Analysis and Forecast, by Application
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Global Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            6.3.1. Solid Organ Transplantation
                     6.3.1.1. Kidney
                     6.3.1.2. Liver
                     6.3.1.3. Heart
                     6.3.1.4. Lungs
                     6.3.1.5. Pancreas
                     6.3.1.6. Small Bowel
            6.3.2. Stem Cell Transplantation
     6.4. Market Attractiveness, by Application

7. Global Transplant Diagnostic Market Analysis and Forecast, by Screening
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Global Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
            7.3.1. Pre-Transplant Diagnostic
            7.3.2. Post-Transplant Diagnostic
            7.3.3. Instruments
     7.4. Market Attractiveness, by Screening

8. Global Transplant Diagnostic Market Analysis and Forecast, by Product & Services
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Global Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            8.3.1. Reagents & Consumables
            8.3.2. Instruments
            8.3.3. Software & Services
     8.4. Market Attractiveness, by Product & Services

9. Global Transplant Diagnostic Market Analysis and Forecast, by End-user
     9.1. Introduction & Definition
     9.2. Key Findings / Developments
     9.3. Global Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
            9.3.1. Hospital & Transplant Centers
            9.3.2. Research Laboratories
            9.3.3. Others
     9.4. Market Attractiveness, by End-user

10. Global Transplant Diagnostic Market Analysis and Forecast, by Region
     10.1.Key Findings
     10.2. Global Transplant Diagnostic Market Value Forecast, by Region
            10.2.1. North America
            10.2.2. Europe
            10.2.3. Asia Pacific
            10.2.4. Latin America
            10.2.5. Middle East & Africa
     10.3.Market Attractiveness, by Country/Region

11. North America Transplant Diagnostic Market Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
     11.2. North America Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
            11.2.1. Molecular Assay
            11.2.2. Non-Molecular Assay
     11.3. North America Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
            11.3.1. Solid Organ Transplantation
                     11.3.1.1. Kidney
                     11.3.1.2. Liver
                     11.3.1.3. Heart
                     11.3.1.4. Lungs
                     11.3.1.5. Pancreas
                     11.3.1.6. Small Bowel
            11.3.2. Stem Cell Transplantation
     11.4. North America Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
            11.4.1. Pre-Transplant Diagnostic
            11.4.2. Post-Transplant Diagnostic
            11.4.3. Instruments
     11.5. North America Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            11.5.1. Reagents & Consumables
            11.5.2. Instruments
            11.5.3. Software & Services
     11.6. North America Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
            11.6.1. Hospital & Transplant Centers
            11.6.2. Research Laboratories
            11.6.3. Others
     11.7. North America Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
            11.7.1. U.S.
            11.7.2. Canada
     11.8. North America Transplant Diagnostic Market Attractiveness Analysis
            11.8.1. By Technique
            11.8.2. By Application
            11.8.3. By Screening
            11.8.4. By Product & Services
            11.8.5. By End-user
            11.8.6. By Country

12. Europe Transplant Diagnostic Market Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
     12.2. Europe Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
            12.2.1. Molecular Assay
            12.2.2. Non-Molecular Assay
     12.3. Europe Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
            12.3.1. Solid Organ Transplantation
                     12.3.1.1. Kidney
                     12.3.1.2. Liver
                     12.3.1.3. Heart
                     12.3.1.4. Lungs
                     12.3.1.5. Pancreas
                     12.3.1.6. Small Bowel
            12.3.2. Stem Cell Transplantation
     12.4. Europe Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
            12.4.1. Pre-Transplant Diagnostic
            12.4.2. Post-Transplant Diagnostic
            12.4.3. Instruments
     12.5. Europe Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            12.5.1. Reagents & Consumables
            12.5.2. Instruments
            12.5.3. Software & Services
     12.6. Europe Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
            12.6.1. Hospital & Transplant Centers
            12.6.2. Research Laboratories
            12.6.3. Others
     12.7. Europe Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
            12.7.1. Germany
            12.7.2. U.K.
            12.7.3. France
            12.7.4. Spain
            12.7.5. Italy
            12.7.6. Rest of Europe
     12.8. Europe Transplant Diagnostic Market Attractiveness Analysis
            12.8.1. By Technique
            12.8.2. By Application
            12.8.3. By Screening
            12.8.4. By Product & Services
            12.8.5. By End-user
            12.8.6. By Country

13. Asia Pacific Transplant Diagnostic Market Analysis and Forecast
     13.1.Introduction
            13.1.1. Key Findings
     13.2. Asia Pacific Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
            13.2.1. Molecular Assay
            13.2.2. Non-Molecular Assay
     13.3. Asia Pacific Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
            13.3.1. Solid Organ Transplantation
                     13.3.1.1. Kidney
                     13.3.1.2. Liver
                     13.3.1.3. Heart
                     13.3.1.4. Lungs
                     13.3.1.5. Pancreas
                     13.3.1.6. Small Bowel
            13.3.2. Stem Cell Transplantation
     13.4. Asia Pacific Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
            13.4.1. Pre-Transplant Diagnostic
            13.4.2. Post-Transplant Diagnostic
            13.4.3. Instruments
     13.5. Asia Pacific Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            13.5.1. Reagents & Consumables
            13.5.2. Instruments
            13.5.3. Software & Services
     13.6. Asia Pacific Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
            13.6.1. Hospital & Transplant Centers
            13.6.2. Research Laboratories
            13.6.3. Others
     13.7. Asia Pacific Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
            13.7.1. China
            13.7.2. Japan
            13.7.3. India
            13.7.4. Australia & New Zealand
            13.7.5. Rest of Asia Pacific
     13.8. Asia Pacific Transplant Diagnostic Market Attractiveness Analysis
            13.8.1. By Technique
            13.8.2. By Application
            13.8.3. By Screening
            13.8.4. By Product & Services
            13.8.5. By End-user
            13.8.6. By Country

14. Latin America Transplant Diagnostic Market Analysis and Forecast
     14.1.Introduction
            14.1.1. Key Findings
     14.2. Latin America Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
            14.2.1. Molecular Assay
            14.2.2. Non-Molecular Assay
     14.3. Latin America Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
            14.3.1. Solid Organ Transplantation
                     14.3.1.1. Kidney
                     14.3.1.2. Liver
                     14.3.1.3. Heart
                     14.3.1.4. Lungs
                     14.3.1.5. Pancreas
                     14.3.1.6. Small Bowel
            14.3.2. Stem Cell Transplantation
     14.4. Latin America Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
            14.4.1. Pre-Transplant Diagnostic
            14.4.2. Post-Transplant Diagnostic
            14.4.3. Instruments
     14.5. Latin America Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            14.5.1. Reagents & Consumables
            14.5.2. Instruments
            14.5.3. Software & Services
     14.6. Latin America Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
            14.6.1. Hospital & Transplant Centers
            14.6.2. Research Laboratories
            14.6.3. Others
     14.7. Latin America Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
            14.7.1. Brazil
            14.7.2. Mexico
            14.7.3. Rest of Latin America
     14.8. Latin America Transplant Diagnostic Market Attractiveness Analysis
            14.8.1. By Technique
            14.8.2. By Application
            14.8.3. By Screening
            14.8.4. By Product & Services
            14.8.5. By End-user
            14.8.6. By Country

15. Middle East & Africa Transplant Diagnostic Market Analysis and Forecast
     15.1.Introduction
            15.1.1. Key Findings
     15.2. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
            15.2.1. Molecular Assay
            15.2.2. Non-Molecular Assay
     15.3. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
            15.3.1. Solid Organ Transplantation
                     15.3.1.1. Kidney
                     15.3.1.2. Liver
                     15.3.1.3. Heart
                     15.3.1.4. Lungs
                     15.3.1.5. Pancreas
                     15.3.1.6. Small Bowel
            15.3.2. Stem Cell Transplantation
     15.4. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
            15.4.1. Pre-Transplant Diagnostic
            15.4.2. Post-Transplant Diagnostic
            15.4.3. Instruments
     15.5. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
            15.5.1. Reagents & Consumables
            15.5.2. Instruments
            15.5.3. Software & Services
     15.6. Middle East & Africa Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
            15.6.1. Hospital & Transplant Centers
            15.6.2. Research Laboratories
            15.6.3. Others
     15.7. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
            15.7.1. GCC countries
            15.7.2. South Africa
            15.7.3. Israel
            15.7.4. Rest of Middle East & Africa
     15.8. Middle East & Africa Transplant Diagnostic Market Attractiveness Analysis
            15.8.1. By Technique
            15.8.2. By Application
            15.8.3. By Screening
            15.8.4. By Product & Services
            15.8.5. By End-user
            15.8.6. By Country

16. Competition Landscape
     16.1.Market Player – Competition Matrix (by Tier and Size of companies)
     16.2.Market Share Analysis by Company (2017)
     16.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            16.3.1. Bio-Rad Laboratories, Inc.
                     16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.1.2. Product Portfolio
                     16.3.1.3. SWOT Analysis
                     16.3.1.4. Financial Overview
                     16.3.1.5. Strategic Overview
            16.3.2. Qiagen N.V.
                     16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.2.2. Product Portfolio
                     16.3.2.3. SWOT Analysis
                     16.3.2.4. Financial Overview
                     16.3.2.5. Strategic Overview
            16.3.3. F. Hoffmann-La Roche AG
                     16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.3.2. Product Portfolio
                     16.3.3.3. SWOT Analysis
                     16.3.3.4. Financial Overview
                     16.3.3.5. Strategic Overview
            16.3.4. Thermo Fisher Scientific, Inc.
                     16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.4.2. Product Portfolio
                     16.3.4.3. SWOT Analysis
                     16.3.4.4. Financial Overview
                     16.3.4.5. Strategic Overview
            16.3.5. Becton, Dickinson and Company
                     16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.5.2. Product Portfolio
                     16.3.5.3. SWOT Analysis
                     16.3.5.4. Financial Overview
                     16.3.5.5. Strategic Overview
            16.3.6. Ortho Clinical Diagnostics
                     16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.6.2. Product Portfolio
                     16.3.6.3. SWOT Analysis
                     16.3.6.4. Financial Overview
                     16.3.6.5. Strategic Overview
            16.3.7. Immucor, Inc.
                     16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.7.2. Product Portfolio
                     16.3.7.3. SWOT Analysis
                     16.3.7.4. Financial Overview
                     16.3.7.5. Strategic Overview
            16.3.8. Illumina, Inc.
                     16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.8.2. Product Portfolio
                     16.3.8.3. SWOT Analysis
                     16.3.8.4. Financial Overview
                     16.3.8.5. Strategic Overview
            16.3.9. Siemens Healthineers (Siemens AG)
                     16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.9.2. Product Portfolio
                     16.3.9.3. SWOT Analysis
                     16.3.9.4. Financial Overview
                     16.3.9.5. Strategic Overview
            16.3.10. Agilent Technologies
                     16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.3.10.2. Product Portfolio
                     16.3.10.3. SWOT Analysis
                     16.3.10.4. Financial Overview
                     16.3.10.5. Strategic Overview
            16.3.11. Others

List of Tables

Table 01: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 02: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 03: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 04: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
Table 05: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 06: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 07: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 08: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 09: U.S. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 10: U.S. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 11: U.S. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 12: U.S. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 13: Canada Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 14: Canada Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 15: Canada Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 16: Canada Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 17: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 18: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 19: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 20: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
Table 21: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 22: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 23: Europe Animal Parasiticides Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 24: France Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 25: France Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 26: France Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 27: France Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 28: U.K. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 29: U.K. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 30: U.K. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 31: U.K. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 32: Germany Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 33: Germany Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 34: Germany Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 35: Germany Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 36: Spain Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 37: Spain Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 38: Spain Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 39: Spain Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 40: Italy Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 41: Italy Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 42: Italy Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 43: Italy Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 44: Rest of Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 45: Rest of Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 46: Rest of Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 47: Rest of Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 48: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 49: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 50: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 51: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
Table 52: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 53: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 54: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 55: Japan Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 56: Japan Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 57: Japan Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 58: Japan Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 59: China Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 60: China Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 61: China Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 62: China Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 63: India Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 64: India Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 65: India Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 66: India Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 67: Australia & New Zealand Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 68: Australia & New Zealand Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 69: Australia & New Zealand Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 70: Australia & New Zealand Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 71: Rest of Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 72: Rest of Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 73: Rest of Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 74: Rest of Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 75: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 76: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 77: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 78: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
Table 79: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 80: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 81: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 82: Brazil Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 83: Brazil Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 84: Brazil Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 85: Brazil Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 86: Mexico Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 87: Mexico Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 88: Mexico Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 89: Mexico Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 90: Rest of Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 91: Rest of Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 92: Rest of Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 93: Rest of Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 94: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 95: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 96: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 97: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
Table 98: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 99: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 100: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 101: GCC countries Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 102: GCC countries Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 103: GCC countries Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 104: GCC countries Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 105: South Africa Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 106: South Africa Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 107: South Africa Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 108: South Africa Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 109: Israel Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 110: Israel Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 111: Israel Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 112: Israel Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 113: Rest of MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 114: Rest of MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 115: Rest of MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 116: Rest of MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 117: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 118: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 119: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 120: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
Table 121: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 122: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures

Figure 01: Global Transplant Diagnostic Market Size (US$ Mn) Forecast, 2016–2026
Figure 02: Global Transplant Diagnostic Market Value Share, by Screening, 2017
Figure 03: Global Transplant Diagnostic Market Value Share, by Application, 2017
Figure 04: Global Transplant Diagnostic Market Value Share, by Technique, 2017
Figure 05: Global Transplant Diagnostic Market Value Share, by End-user, 2017
Figure 06: Global Transplant Diagnostic Market Value Share, by Product & Services, 2017
Figure 07: Global Transplant Diagnostic Market Value Share, by Region, 2017
Figure 08: Global Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
Figure 09: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pre-Transplant Diagnostic, 2017–2026
Figure 10: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Post-Transplant Diagnostic, 2017–2026
Figure 11: Global Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
Figure 12: Global Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
Figure 13: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Molecular Assay, 2017–2026
Figure 14: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Non-Molecular Assay, 2017–2026
Figure 15: Global Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
Figure 16: Global Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
Figure 17: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Stem Cell Transplantation, 2017–2026
Figure 18: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Solid Organ Transplantation, 2017–2026
Figure 19: Global Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
Figure 20: Global Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
Figure 21: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Reagents & Consumables, 2017–2026
Figure 22: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Software & Services, 2017–2026
Figure 23: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Instruments, 2017–2026
Figure 24: Global Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
Figure 25: Global Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
Figure 26: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital & Transplant Centers, 2017–2026
Figure 27: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2026
Figure 28: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Research Laboratories, 2017–2026
Figure 29: Global Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026
Figure 30: Global Transplant Diagnostic Market Value Share, by Region, 2018 and 2025
Figure 31: Global Transplant Diagnostic Market Attractiveness, by Region, 2018–2026
Figure 32: North America Transplant Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 33: North America Transplant Diagnostic Market Value Share, by Country, 2018–2026
Figure 34: North America Transplant Diagnostic Market Attractiveness, by Country, 2018–2026
Figure 35: North America Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
Figure 36: North America Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
Figure 37: North America Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
Figure 38: North America Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
Figure 39: North America Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
Figure 40: North America Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
Figure 41: North America Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
Figure 42: North America Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
Figure 43: North America Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
Figure 44: North America Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026
Figure 45: Europe Animal Parasiticides Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 46: Europe Animal Parasiticides Market Value Share, by Country/Sub-region, 2018–2026
Figure 47: Europe Animal Parasiticides Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 48: Europe Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
Figure 49: Europe Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
Figure 50: Europe Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
Figure 51: Europe Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
Figure 52: Europe Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
Figure 53: Europe Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
Figure 54: Europe Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
Figure 55: Europe Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
Figure 56: Europe Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
Figure 57: Europe Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026
Figure 58: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016?2026
Figure 59: Latin America Transplant Diagnostic Market Value Share, by Country/Sub-region, 2018–2026
Figure 60: Latin America Transplant Diagnostic Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 61: Latin America Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
Figure 62: Latin America Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
Figure 63: Latin America Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
Figure 64: Latin America Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
Figure 65: Latin America Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
Figure 66: Latin America Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
Figure 67: Latin America Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
Figure 68: Latin America Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
Figure 69: Latin America Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
Figure 70: Latin America Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026
Figure 71: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 72: MEA Transplant Diagnostic Market Value Share, by Country/Sub-region, 2018–2026
Figure 73: MEA Transplant Diagnostic Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 74: MEA Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
Figure 75: MEA Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
Figure 76: MEA Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
Figure 77: MEA Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
Figure 78: MEA Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
Figure 79: MEA Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
Figure 80: MEA Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
Figure 81: MEA Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
Figure 82: MEA Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
Figure 83: MEA Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Transplant Diagnostics Market